** = Publikationen gelistet in SCI/SSCI/Pubmed
** Vámos, E; Vántus, VB; Deák, P; Kálmán, N; Sturm, EM; Nayak, BB; Makszin, L; Loránd, T; Gallyas, F Jr; Radnai, B
MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn's disease-like colitis in male mice
FRONT IMMUNOL. 2025; 16: 1558079
Doi: 10.3389/fimmu.2025.1558079
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Vámos, E; Kálmán, N; Sturm, EM; Nayak, BB; Teppan, J; Vántus, VB; Kovács, D; Makszin, L; Loránd, T; Gallyas, F; Radnai, B
Highly Selective MIF Ketonase Inhibitor KRP-6 Diminishes M1 Macrophage Polarization and Metabolic Reprogramming.
ANTIOXIDANTS-BASEL. 2023; 12(10):
Doi: 10.3390/antiox12101790
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Radnai, B; Sturm, EM; Stančić, A; Jandl, K; Labocha, S; Ferreirós, N; Grill, M; Hasenoehrl, C; Gorkiewicz, G; Marsche, G; Heinemann, Á; Högenauer, C; Schicho, R
Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease.
J Crohns Colitis. 2016; 10(9):1087-1095
Doi: 10.1093/ecco-jcc/jjw061
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Antus, C; Radnai, B; Dombovari, P; Fonai, F; Avar, P; Matyus, P; Racz, B; Sumegi, B; Veres, B
Anti-inflammatory effects of a triple-bond resveratrol analog: structure and function relationship.
Eur J Pharmacol. 2015; 748(3):61-67
Doi: 10.1016/j.ejphar.2014.12.009
Web of Science
PubMed
FullText
FullText_MUG
** Sturm, EM; Parzmair, GP; Radnai, B; Frei, RB; Sturm, GJ; Hammer, A; Schuligoi, R; Lippe, IT; Heinemann, A
Phosphoinositide-dependent protein kinase 1 (PDK1) mediates potent inhibitory effects on eosinophils.
Eur J Immunol. 2015; 45(5):1548-1559
Doi: 10.1002/eji.201445196
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sturm, EM; Radnai, B; Jandl, K; Stančić, A; Parzmair, GP; Högenauer, C; Kump, P; Wenzl, H; Petritsch, W; Pieber, TR; Schuligoi, R; Marsche, G; Ferreirós, N; Heinemann, A; Schicho, R
Opposing roles of prostaglandin D2 receptors in ulcerative colitis.
J Immunol. 2014; 193(2):827-839
Doi: 10.4049/jimmunol.1303484
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jakus, PB; Kalman, N; Antus, C; Radnai, B; Tucsek, Z; Gallyas, F; Sumegi, B; Veres, B
TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
J Nutr Biochem. 2013; 24(5):819-823
Doi: 10.1016/j.jnutbio.2012.04.017
Web of Science
PubMed
FullText
FullText_MUG
** Radnai, B; Antus, C; Racz, B; Engelmann, P; Priber, JK; Tucsek, Z; Veres, B; Turi, Z; Lorand, T; Sumegi, B; Gallyas, F
Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation.
Mol Cancer. 2012; 11(5): 34-34.
Doi: 10.1186/1476-4598-11-34
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kálai, T; Borza, E; Antus, C; Radnai, B; Gulyás-Fekete, G; Fehér, A; Sümegi, B; Hideg, K
Synthesis and study of new paramagnetic resveratrol analogues.
Bioorg Med Chem. 2011; 19(24):7311-7317
Doi: 10.1016/j.bmc.2011.10.066
Web of Science
PubMed
FullText
FullText_MUG
** Tucsek, Z; Radnai, B; Racz, B; Debreceni, B; Priber, JK; Dolowschiak, T; Palkovics, T; Gallyas, F; Sumegi, B; Veres, B
Suppressing LPS-induced early signal transduction in macrophages by a polyphenol degradation product: a critical role of MKP-1.
J Leukoc Biol. 2011; 89(1):105-111
Doi: 10.1189/jlb.0610355
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Radnai, B; Tucsek, Z; Bognar, Z; Antus, C; Mark, L; Berente, Z; Gallyas, F; Sumegi, B; Veres, B
Ferulaldehyde, a water-soluble degradation product of polyphenols, inhibits the lipopolysaccharide-induced inflammatory response in mice.
J Nutr. 2009; 139(2): 291-297.
Doi: 10.3945/jn.108.097386
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bognar, Z; Kalai, T; Palfi, A; Hanto, K; Bognar, B; Mark, L; Szabo, Z; Tapodi, A; Radnai, B; Sarszegi, Z; Szanto, A; Gallyas, F; Hideg, K; Sumegi, B; Varbiro, G
A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death.
Free Radic Biol Med. 2006; 41(5): 835-848.
Doi: 10.1016/j.freeradbiomed.2006.06.004
Web of Science
PubMed
FullText
FullText_MUG
** Veres, B; Radnai, B; Gallyas, F; Varbiro, G; Berente, Z; Osz, E; Sumegi, B
Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice.
J Pharmacol Exp Ther. 2004; 310(1): 247-255.
Doi: 10.1124/jpet.104.065151
Web of Science
PubMed
FullText
FullText_MUG